أعرض في EDS

Supplementary Table from Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

التفاصيل البيبلوغرافية
العنوان: Supplementary Table from Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
المؤلفون: Manish R. Patel, Gayle P. Pouliot, Rakesh Kumar, Mayukh Das, Maureen M. Hattersley, Huifang Chen, Elizabeth A. Pilling, Ben S. Sidders, Ganesh Moorthy, Deanna L. Russell, Kris F. Sachsenmeier, Susanna Ulahannan, Janet L. Karlix, Daniel J. George, Jennifer H. Choe, Charles G. Drake, Todd M. Bauer, Gerald S. Falchook, Johanna C. Bendell, Emerson A. Lim
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Supplementary Table from Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0573494165bfd0f28a9dcffcf97ea9f1
https://doi.org/10.1158/1078-0432.22489643.v1
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....0573494165bfd0f28a9dcffcf97ea9f1
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.